These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7829291)

  • 1. Decrease of serum iron in acutely psychotic schizophrenic patients.
    Weiser M; Levkowitch Y; Neuman M; Yehuda S
    Int J Neurosci; 1994 Sep; 78(1-2):49-52. PubMed ID: 7829291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperdopaminergia in schizophreniform psychosis: a chronobiological study.
    Rao ML; Gross G; Halaris A; Huber G; Marler M; Strebel B; Bräunig P
    Psychiatry Res; 1993 May; 47(2):187-203. PubMed ID: 8341771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma dopamine concentrations in unmedicated acute schizophrenics.
    Sarai M; Matsunaga H; Kimura S
    Jpn J Psychiatry Neurol; 1990 Sep; 44(3):557-62. PubMed ID: 2074615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron deficiency-induced circadian rhythm reversal of dopaminergic-mediated behaviours and thermoregulation in rats.
    Youdim MB; Yehuda S; Ben-Uriah Y
    Eur J Pharmacol; 1981 Sep; 74(4):295-301. PubMed ID: 7197630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute drug-induced akathisia is not associated with low serum iron status.
    Sachdev P; Loneragan C
    Psychopharmacology (Berl); 1991; 103(1):138-9. PubMed ID: 1672456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma prolactin response to domperidone in acute schizophrenia and schizophreniform illness.
    Nerozzi D; Magnani A; Sforza V; Scaramucci E; Cerilli M; Moretti C; Frajese G; Antonozzi I; Meltzer HY
    Psychiatry Res; 1990 Nov; 34(2):139-47. PubMed ID: 2149613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The increased opiate action of beta-endorphin in iron-deficient rats: the possible involvement of dopamine.
    Yehuda S; Youdim MB
    Eur J Pharmacol; 1984 Sep; 104(3-4):245-51. PubMed ID: 6094214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum iron and ferritin in acute neuroleptic akathisia.
    Hofmann M; Seifritz E; Botschev C; Kräuchi K; Müller-Spahn F
    Psychiatry Res; 2000 Apr; 93(3):201-7. PubMed ID: 10760378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum melatonin levels in schizophrenic and schizoaffective hospitalized patients.
    Robinson S; Rosca P; Durst R; Shai U; Ghinea C; Schmidt U; Nir I
    Acta Psychiatr Scand; 1991 Sep; 84(3):221-4. PubMed ID: 1950621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia.
    Miodownik C; Meoded A; Libov I; Bersudsky Y; Sela BA; Lerner V
    Clin Neuropharmacol; 2008; 31(4):197-203. PubMed ID: 18670243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.
    Pearlson GD; Wong DF; Tune LE; Ross CA; Chase GA; Links JM; Dannals RF; Wilson AA; Ravert HT; Wagner HN
    Arch Gen Psychiatry; 1995 Jun; 52(6):471-7. PubMed ID: 7771917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian rhythm of plasma 11-hydroxycorticosteroids in psychiatric disorders.
    Conroy RT; Hughes BD; Milles JN
    Br Med J; 1968 Aug; 3(5615):405-7. PubMed ID: 5667319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deficiency alters the day-night variation in monoamine levels in mice.
    Bianco LE; Unger EL; Earley CJ; Beard JL
    Chronobiol Int; 2009 Apr; 26(3):447-63. PubMed ID: 19360489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin levels in drug-naïve patients with schizophrenia and other psychotic disorders.
    Petrikis P; Tigas S; Tzallas AT; Archimandriti DT; Skapinakis P; Mavreas V
    Int J Psychiatry Clin Pract; 2016 Sep; 20(3):165-9. PubMed ID: 27334805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients.
    Davila R; Zumarraga M; Andia I; Friedhoff AJ
    Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M; Davis KL
    Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain.
    Erikson KM; Jones BC; Hess EJ; Zhang Q; Beard JL
    Pharmacol Biochem Behav; 2001; 69(3-4):409-18. PubMed ID: 11509198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia.
    Rao ML; Strebel B; Halaris A; Gross G; Bräunig P; Huber G; Marler M
    Psychiatry Res; 1995 Jun; 57(1):21-39. PubMed ID: 7568556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobehavioral analysis of developmental iron deficiency in rats.
    Beard JL; Erikson KM; Jones BC
    Behav Brain Res; 2002 Aug; 134(1-2):517-24. PubMed ID: 12191838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P-like immunoreactivity in plasma of psychotic patients and effects of neuroleptics and electroconvulsive therapy.
    Kaiya H; Tamura Y; Adachi S; Moriuchi I; Namba M; Tanaka M; Yoshida H; Yanaihara N; Yanaihara C
    Psychiatry Res; 1981 Aug; 5(1):11-21. PubMed ID: 6169105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.